KVUE

Tillett Caroline

Known title: Chief Scientific OfficerCIK: 0001966949

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Kenvue Affected by Kimberly-Clark Bond Sale and Earnings Outlook. Kimberly-Clark is preparing a bond sale before its planned purchase of Kenvue, which could influence Kenvue's capital structure and investor perception. Analysts expect Kenvue's next quarterly earnings to reflect the impact of the acquisition and current market conditions. The company’s 2026 profit outlook remains unchanged, and consumer stocks overall were mixed in recent trading sessions.

this person other insiders at KVUE

Transaction History

KVUE▲ Buy$0
KVUE▼ Sell$205K
KVUE▲ Buy$0
KVUE▼ Sell$26K
KVUE▼ Sell$39K
KVUE▲ Buy$0
KVUE▼ Sell$30K
KVUE▲ Buy$0
KVUE▲ Buy$0
KVUE▼ Sell$14K
KVUE▲ Buy$0
KVUE▼ Sell$35K
KVUE▲ Buy$0
KVUE▼ Sell$57K
KVUE▲ Buy$0
KVUE▼ Sell$136K
KVUE▲ Buy$0
KVUE▼ Sell$21K
KVUE▲ Buy$0
KVUE▼ Sell$18K
KVUE▲ Buy$0
KVUE▼ Sell$20K
KVUE▼ Sell$137K
KVUE▲ Buy$0
KVUE▼ Sell$44K
KVUE▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.